Regulation & law · 07/06/2024

DEA Stays Hearing on Proposed Placement of DOI and DOC in Schedule I

The Drug Enforcement Administration has stayed the June 10, 2024 hearing on the proposed placement of two phenethylamine hallucinogens, as identified in the proposed rule, in schedule I of the Controlled Substances Act. The DEA has temporarily halted the scheduled hearing on the placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I.